Molecular profiling and targeted therapy in advanced endometrial cancer.

被引：0
|
作者：
Wilson, Michelle K.
Bedard, Philippe L.
Joshua, Anthony M.
Mackay, Helen
Butler, Marcus O.
Dhani, Neesha C.
Lheureux, Stephanie
Martin-Lorente, Cristina
Rodriguez-Freixinos, Victor
Clarke, Blaise
Shaw, Patricia
Milea, Anca
Wang, Lisa
Kamel-Reid, Suzanne
Stockley, Tracy
Bruce, Jeff
Pugh, Trevor John
Oza, Amit M.
机构：
[1] Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[3] Univ Toronto, Dept Med, Div Med Oncol & Hematol, Toronto, ON, Canada
[4] Univ Hlth Network, Dept Pathol & Lab Med, Toronto, ON, Canada
[5] Univ Hlth Network, Toronto, ON, Canada
[6] Princess Margaret Canc Ctr, Dept Biostat, Toronto, ON, Canada
[7] Ontario Canc Inst, Princess Margaret Canc Ctr, Toronto, ON M4X 1K9, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.5589
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5589
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Low molecular weight heparin (LMWH) therapy and survival in advanced cancer.
    Kakkar, AK
    Kadziola, Z
    Williamson, RCN
    Levine, MN
    Low, V
    Lemoine, NR
    BLOOD, 2002, 100 (11) : 148A - 148A
  • [22] Therapy selection in patients with advanced bladder cancer. Is molecular biology helpful?
    Junker, K.
    Hartmann, A.
    Stoeckle, M.
    UROLOGE, 2012, 51 (06): : 805 - 812
  • [23] Molecular targeted therapy for lung cancer. (vol 366, pg 1507, 2005)
    Onn, A
    Herbst, RS
    LANCET, 2005, 366 (9500): : 1848 - 1848
  • [24] The role of molecular pathology in thyroid cancer. Tumor diagnostics, cytology and targeted therapy
    Schmid, K. W.
    Fuehrer, D.
    ONKOLOGE, 2015, 21 (07): : 584 - +
  • [25] Geographic disparities in prescribing patterns of molecularly targeted therapy in advanced and recurrent endometrial cancer
    Lee, Grace
    Evans, Elizabeth
    Harsono, Alfonsus Adrian
    Pothuri, Bhavana
    Backes, Floor
    Moore, Kathleen
    Thaker, Premal
    Jackson, Amanda
    Wright, Jason
    Ko, Emily
    Konecny, Gottfried
    Crafton, Sarah
    Duska, Linda
    Corr, Bradley
    Castellano, Tara
    Puechl, Allison
    Bae-Jump, Victoria
    Clements, Aine
    Smitherman, Carson
    Secord, Angeles Alvarez
    Arend, Rebecca
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S349 - S350
  • [26] Efficacy of combination of immune checkpoint inhibitors, chemotherapy, and targeted therapy in advanced/refractory cancer.
    Salem, Philip A.
    Gensini, Lorenzo
    McCallum, William G. B.
    Hanna, John
    Wheeler, Thomas M.
    Stenoien, Randall A.
    Jabboury, Khaled W.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (23_SUPPL) : 41 - 41
  • [27] Pathology of the future: Molecular profiling for targeted therapy
    Espina, V
    Geho, D
    Mehta, AI
    Petricoin, EF
    Liotta, LA
    Rosenblatt, KP
    CANCER INVESTIGATION, 2005, 23 (01) : 36 - 46
  • [28] CARBOPLATIN THERAPY IN ADVANCED ENDOMETRIAL CANCER
    GREEN, JB
    GREEN, S
    ALBERTS, DS
    OTOOLE, R
    SURWIT, EA
    NOLTIMIER, JW
    OBSTETRICS AND GYNECOLOGY, 1990, 75 (04): : 696 - 700
  • [29] Systemic therapy for advanced endometrial cancer
    Tazi, Youssef
    Pautier, Patricia
    Lhomme, Catherine
    BULLETIN DU CANCER, 2012, 99 (01) : 93 - 97
  • [30] Systemic therapy for advanced endometrial cancer
    Pautier, Patricia
    Pommeret, Fanny
    BULLETIN DU CANCER, 2017, 104 (12) : 1046 - 1053
12345